Anzeige
Mehr »
Sonntag, 06.07.2025 - Börsentäglich über 12.000 News
Surfen Sie die heißeste Edelmetall-Welle des Jahrzehnts! Dieses TOP-Unternehmen zündet nächste Wachstumsstufe!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
123 Leser
Artikel bewerten:
(0)

Diabetes Care Devices Market to Reach $38.3 Bn, Globally, by 2030 at 6.6% CAGR: Allied Market Research

Increase in the incidence of diabetes and rise in sedentary lifestyle across the globe drive the global diabetes care devices market.

PORTLAND, Ore., May 12, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Diabetes Care Devices Market by By Product (Blood Glucose Monitoring Devices, Insulin Delivery Devices): Global Opportunity Analysis and Industry Forecast, 2020-2030." According to the report, the global diabetes care devices industry was estimated at $20.0 billion in 2020, and is expected to hit $38.3 billion by 2030, registering a CAGR of 6.6% from 2021 to 2030.

Allied_Market_Research_Logo

Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/2842

Drivers, restraints, and opportunities-

Increase in the incidence of diabetes and rise in sedentary lifestyle across the globe drive the global diabetes care devices market. On the other hand, adverse effects associated with some of the diabetes care devices restrain the growth to some extent. However, surge in awareness about diabetes monitoring devices is anticipated to create lucrative opportunities in the industry.

Covid-19 scenario-

  • Diabetic people call for constant access to insulin along with top-graded care. Therefore, growing adoption of insulin pens and continuous glucose monitoring expedients gave way to increased demand for optimal management of the disease. This factor impacted the growth of the global diabetes care devices market positively.
  • This trend is most likely to persist post pandemic as well.

Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/2842

The insulin delivery devices segment to retain the lion's share-

By product, the insulin delivery devices segment contributed to the lion's share in 2020, holding nearly three-fifths of the global diabetes care devices market. This is attributed to surge in the prevalence of diabetes across the globe. However, the blood glucose monitoring devices segment is projected to manifest the fastest CAGR of 7.2% from 2021 to 2030, owing to increase in adoption of diabetes care devices among the geriatric population.

North America garnered the major share in 2020-

By region, North America dominated in 2020, garnering around two-fifths of the global diabetes care devices market. Increase in the aging population and upsurge in product launches across North America fuels the market growth. The Asia-Pacific region, on the other hand, is expected to cite the fastest CAGR of 7.6% throughout the forecast period, due to rise in healthcare expenditure and increase in adoption of novel diabetes care devices in the province.

Key players in the industry-

  • ACON Laboratories, Inc.
  • Ascension Diabetes Care Holdings AG
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Medline Industries
  • Novo Nordisk A/S
  • Terumo Corporation
  • Johnson & Johnson
  • Nipro corporation

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Medical Cannabis Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Oncology/Cancer Drugs Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Workplace Stress Management Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

HIV Drugs Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Disposable Gloves Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Equine Healthcare Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Digital Therapeutics Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Sleep Aids Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Surgical Robotics Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Medical Spa Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

© 2022 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.